Table 2.
Treatment Effect Test |
Heterogeneity Test |
|||||
---|---|---|---|---|---|---|
Outcome | Mean Differencea | p Valueb | Q Valuec (df) | p Valued | I2, %e | Tauf |
Buccolingual | 1.89 (1.41, 2.36) | < .001 | 12.28 (5) | .031 | 59.3 | 0.44 |
Midbuccal | 2.07 (1.03, 3.12) | < .001 | 48.83 (5) | <.001 | 89.8 | 1.22 |
Midlingual | 1.18 (0.17, 2.19) | .022 | 35.77 (4) | <.001 | 88.8 | 1.08 |
Mesial | 0.48 (0.18, 0.79) | .002 | 5.33 (4) | .26 | 24.9 | 0.17 |
Distal | 0.24 (–0.05, 0.53) | .102 | 2.92 (4) | .57 | 0.0 | 0.0 |
The effect size estimated is the difference (treatment – control) in mean change in the specified alveolar bone measurement and represents the gain associated with treatment. Values in millimeters, mean (95% confidence interval).
Significance probability associated with the test of a significant treatment effect.
Test statistic and degrees of freedom associated with the Cochran Q test of heterogeneity of treatment effect among studies.
Significance probability associated with the Cochran Q test of heterogeneity of treatment effect among studies.
Estimated proportion of total variation across studies that is due to heterogeneity.
Estimate of the standard deviation of underlying effects across studies, reflecting variability among effect sizes.